Alzheimer’s disease

A new analytical platform reveals signature changes in immune cells of the brain during aging and neurodegenerative conditions such as Alzheimer’s disease.

By selectively switching on neurons with light, scientists can piece together crucial events in Alzheimer’s disease progression.

A large-scale genome study suggests that Alzheimer’s and an eye disorder called glaucoma share a common disease development pathway.

Single-cell genomic technology is providing fresh perspectives on the origins of microglia, ancient immune sentinels found in the brain.

Researchers at A*STAR are growing better models of aging brain diseases in the search to stop the decline

Fluorescent probe selectively detects biomarkers linked to Alzheimer’s disease

Insight into the mechanism of protein aggregation provides a model system that could lead to treatments for several associated diseases